Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) Director Julie Mchugh sold 22,766 shares of the firm’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $6.29, for a total value of $143,198.14. Following the transaction, the director now owns 139,528 shares of the company’s stock, valued […]
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) have received a consensus rating of “Buy” from the five research firms that are presently covering the company, Marketbeat reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have covered the stock in […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has earned an average rating of “Buy” from the four research firms that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have covered the stock in the last […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Equities research analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Ironwood Pharmaceuticals in a report issued on Monday, September 25th. Zacks Research analyst A. Chakraborty now forecasts that the biotechnology company will post earnings of $0.23 per share for the […]
Foundry Partners LLC raised its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 5.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 481,902 shares of the biotechnology company’s stock after buying an additional 26,487 shares during the quarter. Foundry Partners […]